Readers come to books like this one looking for a magic bullet, like a supplement or protocol or morning routine, that can be added to an otherwise unaltered life and fix what the unaltered life has been doing for decades. This book does not provide that. What it provides is considerably more demanding and considerably more effective: the argument that the lifestyle itself needs to change, and a detailed account of what that change looks like lived out over forty years.
There Is A Better WayTM. It begins not with a supplement stack but with the recognition that the supplement stack and the lifestyle have to point in the same direction. You cannot supplement your way out of a diet working against the supplements. You cannot exercise your way out of a food supply engineered to defeat the satiety signals that exercise depends on. You cannot take the senolytic stack on Sunday and eat the food that accelerates senescence the other six days.
This chapter explains what lifestyle will enable the supplements to work, and why the lifestyle, seriously implemented, is itself the most powerful intervention available.
Stop killing yourself. There is a better way.
Squaring the Curve
A critical distinction that longevity literature makes, but that most popular health writing ignores, matters enormously for how you read this chapter.
Extending maximum lifespan — pushing the biological ceiling higher — is the project of the Annual Increment chapter. That chapter concerns itself with compounds that extend lifespan in model organisms, reverse epigenetic aging clocks, and address the hallmarks of aging at the molecular level. It is asking: how far can the ceiling go?
This chapter asks a different question: how do we stop dying so far below the ceiling that already exists?
The average American man dies at approximately 76 years. The biological maximum lifespan for humans — the ceiling toward which the Annual Increment protocol is climbing — is conservatively estimated at 120 years based on the most validated human supercentenarian data. The gap between 76 and 120 is not primarily genetic. It is primarily lifestyle.
Modern medicine deserves credit for the gains it produced. Antibiotics, vaccines, and surgical advances eliminated causes of early death that were universal before the twentieth century. The person alive at 76 today would likely have died at 40 from tuberculosis or at 55 from a surgically correctable condition in 1900. That achievement is real.
But the decades gained have been partially occupied by a different set of diseases — chronic, metabolic, and largely absent from populations that died of infections before encountering them. Cardiovascular disease, type 2 diabetes, and Alzheimer’s were not waiting patiently for everyone to survive long enough to develop them. They are substantially products of the modern food system, chemical environment, and sedentary lifestyle that accompanied the same industrialization that produced the antibiotics. Trading infectious death for chronic disease is an improvement. It is not the same as health.
Squaring the curve means compressing morbidity — maintaining full function as close to the biological maximum as possible and declining sharply only at the end, rather than spending the last ten to twenty years in the progressive deterioration that most Americans accept as normal aging. It means my dad being able to enjoy one of his favorite restaurants, Stephenson’s Apple Farm, at 70 like he did at 60. It means being asked by a woman at the gym if I was the hunk she saw at the pool — because it is so unusual these days.
What does it mean to stop killing yourself? The mechanisms by which most Americans are killing themselves are now understood with a clarity that was unavailable to previous generations. The gut-brain axis that connects intestinal microbiome composition to neurological function, mood, and blood pressure was not characterized until recently. The role of specific gene variants in personalizing disease risk could not be assessed without the DNA testing now available to anyone with an internet connection and fifty dollars. The specific compounds in factory food that produce endocrine disruption, gut microbiome dysbiosis, and metabolic syndrome were not identified until after it was epidemic.
This chapter presents what forty years of reading, experimentation, and careful observation has produced. It is not a diet plan. It is a modern scientific framework for understanding what lifestyle actually does to the body — and what to do about it.
The Anticipatory Principle
Homo sapiens possesses something no other species has deployed to this degree: the capacity to model a future state and act in the present to change it. Every other animal responds reflexively to immediate conditions. The human brain runs simulations. It anticipates. This capacity produced fire, agriculture, medicine, engineering, and civilization. It can also produce a supplement protocol, a dietary architecture, and the chapters in this book.
The Anticipatory Principle, as applied here, is simple: identify what is coming, and position your defenses before it arrives. Do not pretend the bus doesn’t exist before crossing the street. Look both ways.
Taking the blood glucose management stack thirty minutes before a large starchy meal is the Anticipatory Principle in its most basic form — the enzyme inhibitors positioned in the intestine before the substrate arrives. Silymarin Complex taken before a glass of wine is the same principle applied to hepatotoxic challenge: the liver is about to receive a compound it must detoxify, and the silybin complex upregulates the glutathione synthesis and cellular membrane stabilization that the hepatocytes will need before they need it.
The seaweed chelation taken thirty minutes before the Omura’s cilantro protocol is a more sophisticated expression. The cilantro mobilizes heavy metals from tissues into the bloodstream. Some of those mobilized metals will re-enter the intestinal tract through bile secretion — a second opportunity for absorption that the first-pass chelation missed. The seaweed and sodium alginate are positioned in the intestine to intercept the returning metals before they can be reabsorbed. The first chelation removes what was accessible. The Anticipatory Principle catches what the first pass missed on the way back.
Oxidative stress is among the most predictable challenges the body faces. You know when the stress will arrive so you have the antioxidant defense positioned before the challenge arrives rather than deployed after the damage has occurred. Exercise is the most obvious application: the HIIT session that barely leaves the exercycle surviving generates a controlled oxidative burst that is part of its hormetic benefit, but the surrounding tissue damage is best addressed by having the antioxidant architecture already in place when the burst occurs. Taking the Life Extension Mix, the vitamin C, and NAC before the workout rather than after positions the defense before the oxidative challenge rather than responding to it afterward.
The same logic extends to extended sun exposure — UV radiation generating reactive oxygen species in skin tissue at rates that brief exposure doesn’t approach. The astaxanthin that crosses the blood-brain barrier and inserts into cellular membranes, the vitamin C running at therapeutic levels, the carotenoid matrix from the MacuGuard — all more effective positioned before the UV challenge than applied afterward. The practical result of the daily antioxidants I take is that I can stay out in the sun two to three times longer without burning — not from blocking UV but from having the cellular antioxidant architecture in place to address its oxidative consequences before they cascade into the inflammatory response that produces burning. The protocol that was running for other reasons is simultaneously providing photoprotection. This is what it looks like when interventions are genuinely connected rather than merely additive. Multiple elements of the protocol actually prevent sunburn damage: caffeine absorbs UVB radiation directly before it reaches skin cell DNA; it enhances apoptosis of UV-damaged cells through ATR kinase inhibition; it inhibits UV-induced tumor formation in mouse models. So green tea and coffee are not just for waking up. The suntan lotion is on the inside.
Eating out adds a different oxidative dimension: unknown cooking oils, unknown food quality, unknown processing methods, the emulsifiers and preservatives that may accompany restaurant food regardless of the menu’s presentation. The great excess of calories will have to be burned off in futile energy cycles which generate enormous quantities of free radicals and ROS. A Life Extension Mix tablet with NAC before the meal positions the glutathione synthesis and the antioxidant matrix before the unknown oxidative load rather than after.
The Anticipatory Principle applied to oxidation: identify the challenge before it arrives, position the defense first. The damage that didn’t happen requires no repair.
This is what distinguishes a protocol from a habit. A habit is a response pattern to existing conditions. A protocol is a designed system that anticipates future conditions and acts before they materialize. The human animal is the only one capable of the latter.
And at the largest scale — the existential scale — the entire project of this book is the Anticipatory Principle applied to aging and death. We see what is coming. We see it in the family history, in the mortality statistics, in the man at Stephenson’s Apple Farm who could manage only a single bite of his favorite meal before being done. We can look for that bus before crossing.
The Hormetic Principle
The conventional toxicological model assumes that the dose-response relationship is linear — more of a harmful substance produces proportionally more harm. The hormetic model says this is wrong for biological systems, which evolved under conditions of intermittent challenge and developed adaptive responses to mild stressors that produce net benefit at low doses.
The Hormetic Principle runs through the protocol from exercise to fasting to food that bites back. Controlled muscle damage from intense exercise triggers repair beyond the pre-exercise baseline — the adaptation that produces strength and cardiovascular improvement. Mild caloric restriction activates AMPK and suppresses mTOR — the maintenance-over-growth shift that caloric abundance suppresses. The 16:8 fasting window produces the nutrient scarcity signal that triggers autophagy — the cellular housekeeping that continuous feeding prevents.
Food that bites back is the most accessible daily expression of the hormetic principle. Capsaicin activating TRPV1 receptors, producing endorphins and metabolic activation. Mustard seeds’ isothiocyanates activating Nrf2 — the master regulator of antioxidant and detoxification gene expression. Ginger’s gingerols. Wasabi’s allyl isothiocyanate. Black pepper’s piperine. These are mild biological challenges that the body responds to by upregulating protective systems beyond baseline — the plant’s defensive chemistry becoming the human’s adaptive stimulus.
The sedentary person eating engineered food that requires no adaptive response is not avoiding hormetic stress. They are depriving their adaptive systems of the calibration signals those systems evolved to receive. The atrophy is not just muscular. It is systemic — the repair machinery, the detoxification pathways, the antioxidant systems all running below their adaptive capacity because the challenges that calibrate them are absent.
The immune system requires calibration through exposure to the microbial and environmental diversity it evolved alongside. The gut-associated lymphoid tissue that constitutes 70-80% of the immune system is trained by the microbiome, which is itself shaped by environmental exposure. Reduced microbial diversity from over-sanitized environments, antibiotic overuse, and loss of contact with soil organisms produces immune systems that are simultaneously under-stimulated by pathogens and over-reactive to harmless environmental antigens — hence the autoimmune and allergy epidemic running alongside the sanitization of the modern environment.
Use it or lose it. The mild challenge, precisely dosed, produces the response. The food that bites back can truly be invigorating.
Endothelial Function: The Cardiovascular Risk Factor Your Doctor Doesn’t Measure
Your physician measures your cholesterol. Your physician measures your blood glucose. If both numbers fall within acceptable ranges, you are told your cardiovascular risk is under control. This assessment is incomplete. For the person with familial cardiac history, it may be dangerously incomplete.
The endothelium is a single-cell-thick layer lining every artery in the body. It is the interface between the bloodstream and every organ that blood supplies — heart, brain, kidneys, eyes, extremities. Endothelial cells produce nitric oxide through the enzyme endothelial nitric oxide synthase (eNOS), which signals the smooth muscle cells surrounding each artery to relax and dilate, controlling blood flow in real time. When endothelial function is healthy, the arterial system responds dynamically to the body’s changing oxygen demands. When endothelial function fails, the system rigidifies. Blood pressure rises. Clots form. Plaques develop. Arteries narrow.
The consequences of endothelial dysfunction — diminished circulation, hypertension, thrombosis, and atherosclerosis — are the actual mechanisms of stroke and heart attack. They can be developing for decades in people whose standard lipid and glucose panels appear normal.
Mainstream medicine has no standard test for endothelial function. Flow-mediated dilation (FMD), which measures how well blood vessels respond to endothelial signaling in real time, is the best predictor of progressive arterial stiffening and future cardiovascular events. Carotid intima-media thickness (CIMT), measured by ultrasound, shows how much vascular damage has already accumulated from years of endothelial dysfunction. The CIMT test, in particular, is the structural evidence of what the endothelium has been experiencing — the thicker the carotid artery wall, the greater the risk for stroke or heart attack. Neither test is part of standard cardiovascular screening. Both would have told different stories, years before the events they predict.
Two things destroy eNOS: aging and oxidative stress. Aging reduces eNOS expression progressively. Oxidative stress — from chronic inflammation, from glycation, from the endocrine-disrupting compounds in the modern food supply, from the chronic low-grade inflammatory environment produced by the twenty-to-one seed oil ratio — destroys whatever eNOS remains. The result is a progressive loss of the system that regulates blood flow through every organ in the body.
The nutritional architecture addresses endothelial function from multiple independent directions simultaneously. Amla extract — taken for over a decade primarily for blood glucose management — turned out in the clinical literature to be the most comprehensively studied natural endothelial function intervention available. In metabolic syndrome patients with known endothelial dysfunction, amla reduced arterial stiffness by 6.6-7.5% in twelve weeks while placebo produced a 1.3% worsening. In diabetics, a 7.6% stiffness reduction versus 1.3% worsening in placebo. In smokers, improvement on every measured cardiovascular parameter simultaneously. It enhances nitric oxide production, reduces oxidative stress through three independent pathways, lowers blood pressure, improves lipid profiles, reduces platelet aggregation, and suppresses the aldose reductase enzyme that produces sorbitol — implicated in both cataract formation and arterial stiffening. Olive leaf extract acts as a natural ACE inhibitor equivalent to prescription Captopril while simultaneously enhancing nitric oxide. Pomegranate extract reduced carotid intima-media thickness by up to 35% in three-year clinical trials of carotid artery stenosis patients — the structural arterial damage of endothelial dysfunction being reversed, not merely stabilized. Pine bark extract reduces endothelin-1 by 20%, one of the most potent vasoconstrictors known, while inhibiting HMG-CoA reductase through a mechanism that doesn’t deplete CoQ10 or produce myopathy. Aged black garlic’s SAC enhances hydrogen sulfide production — the gasotransmitter with endothelial protective mechanisms parallel to nitric oxide.
Arginine — the substrate from which eNOS produces nitric oxide — is taken daily, including on non-workout days at half the pre-workout dose, specifically to maintain eNOS substrate availability. SOD Booster delivers oral superoxide dismutase that protects eNOS from oxidative destruction — the two-year CIMT study showing declining arterial thickness in supplemented subjects while controls deteriorated steadily.
The person whose physician measures cholesterol and glucose and finds nothing alarming may still have the endothelial function of an artery preparing for a cardiac event. The endothelium is where the cardiovascular killing starts. It is largely invisible to standard medical assessment — neither CPET measuring VO2 max nor EndoPAT reactive hyperemia testing, the two direct measures of endothelial and cardiovascular function, appear on a routine physical’s checklist despite VO2 max being among the strongest single predictors of longevity in the primary literature. Both are available through cardiologists and longevity clinics for patients who request them specifically. The endothelium responds dramatically to the nutritional and lifestyle interventions documented above. The first step is knowing it exists and knowing it matters.
The Gut-Brain Axis: The Second Brain Your Doctor Doesn’t Discuss
Until recently, the gut was understood as a digestive organ. Food enters, nutrients are extracted, waste is eliminated. The biological story they told seemed simple, but it was wrong.
The enteric nervous system is a network of approximately 500 million neurons lining the gastrointestinal tract, and is now understood as the second brain. It communicates bidirectionally with the central nervous system through the vagus nerve and through chemical signaling that produces systemic effects across every organ system. The gut microbiome — the community of approximately 100 trillion microorganisms living in the gastrointestinal tract, outnumbering human cells ten to one — is now understood as a metabolic organ in its own right, producing neurotransmitters, regulating immune function, modulating blood pressure, and communicating with the brain through pathways that were entirely invisible to medicine until the last decade.
Healthy centenarians have gut microbiome signatures similar to those of much younger people. The microbiome normally ages, but centenarians’ microbiomes stayed young.
The gut-brain axis connection to blood pressure is one of the most recently documented and most striking. Kefir, the fermented milk beverage teeming with diverse probiotic populations, reduces systolic blood pressure in hypertensive adults through multiple mechanisms: bioactive peptides that act as natural ACE inhibitors (the same mechanism as prescription Captopril), improved gut barrier function that reduces the circulating bacterial toxins that impair endothelial function, and — most remarkably — reduced neuroinflammation in brain regions that regulate blood pressure. The gut is communicating with the blood pressure regulation centers in the brain. Changing the gut microbiome changes what those brain regions are being told.
The gut-brain axis connection to mood and depression is equally compelling. The gut produces approximately 90% of the body’s serotonin — the neurotransmitter whose deficiency is the presumed target of most antidepressant medications. Gut microbiome dysbiosis produces altered tryptophan metabolism that reduces serotonin synthesis independently of anything happening in the brain. The MTHFR folate methylation deficit that impairs serotonin synthesis in the brain is operating simultaneously with the gut microbiome dysbiosis that impairs serotonin production in the gut. Two independent pathways to the same neurotransmitter deficit from two entirely different locations in the body are both addressable through diet and supplementation rather than pharmaceuticals.
The connection to cognitive function is now documented across multiple studies. Specific bacterial species — Bifidobacterium longum, Lactobacillus helveticus — produce measurably improved anxiety and cognitive function scores in human trials. LEF put these 2 cultures in their FLORASSIST Mood Improve product. The gut-brain axis operates as a two-way information channel: what lives in the gut shapes what happens in the brain.
The Microbiotic Diet
The term “microbiotic” is used here as a deliberate coinage — not macrobiotic, which describes a philosophy of food balance, but microbiotic, emphasizing deliberate cultivation of the microbiota through dietary choices.
The Microbiotic Diet emphasizes microbiota: yogurt and kefir, yeasts, aged cheese, miso and tempeh, microalgae, sauerkraut. Unicellular organisms are ultimately the very bottom of the food chain. Vegetarianism includes this most practical expression of the Microbiotic Diet.
The Sardinians perfected over 2,000 years ago the use of a local bacterial culture to create their signature pecorino romano. They called it Scotta Fermento — whey culture. The terminology is exact: something living was being cultured, maintained, and deliberately transferred from one batch to the next. The shepherd who named the practice understood its operating principle more precisely than Jan Baptist van Helmont, one of Europe’s most sophisticated natural philosophers, who published detailed instructions for producing mice from discarded shirts and wheat. Pasteur settled the spontaneous generation debate in 1859 with his swan-neck flask experiment. The Sardinian shepherd had settled it operationally two thousand years earlier and named his conclusion correctly: it’s a culture. Something is alive in there. Don’t let it die.
The same population that maintained a specific bacterial culture for two thousand years of cheesemaking also produces a disproportionate fraction of the world’s centenarians. The culture and the longevity are probably not unrelated.
The yogurt protocol — twelve-hour fermented at body temperature, puckering-sour, with the full bacterial activity that commercial yogurt’s shorter fermentation and lower temperatures don’t achieve — is the daily anchor of the Microbiotic Diet. The kefir literature adds a more diverse probiotic population with ACE-inhibitor peptides and gut-brain axis blood pressure benefits. Many global, ancient culinary traditions emphasized the use of fermentation have been shown to have health benefits besides just tasting good.
The blueberry extract taken twice daily acts as a selective prebiotic feeding Bifidobacterium and Lactobacillus species specifically. The diverse plant fiber from the organic garden years and the current protocol provides the fermentable substrate that produces the butyrate that maintains the intestinal barrier integrity that prevents the leaky gut that drives systemic inflammation. The berberine modulates bile acid composition that communicates with the microbiome through independent chemical signaling.
For the reader whose diet more closely resembles the standard American version, LEF’s FLORASSIST probiotic supplement line provides a rapid microbiome intervention: clinical trials in 81-year-old adults showing improved Akkermansia, Bifidobacterium, and Lactobacillus populations, reduced inflammatory Proteobacteria, increased butyrate production, and reduced CRP at 24 weeks. A cholesterol-specific strain producing 22% total cholesterol reduction in six weeks. The quick fix buys time while the dietary foundation is established.
The Microbiotic Diet is not a temporary intervention. It is the permanent dietary architecture that maintains the gut microbiome composition that the gut-brain axis uses to regulate blood pressure, mood, cognition, immunity, and metabolic function simultaneously. What lives in the gut shapes what happens everywhere else.
Feed Your Gut – Not Your Stomach
The individual organism model of the human body is wrong in a specific and quantifiable way. The body contains approximately 30 trillion human cells and approximately 38 trillion microbial cells — roughly equal by count, more microbial than human. The human genome encodes approximately 20,000 protein-coding genes. The collective microbiome encodes 2-20 million. The genetic material in a human body is overwhelmingly not human genetic material. What we call “the human body” is more accurately described as a holobiont — a host organism plus its entire complement of symbiotic microorganisms, considered as a functional unit. The human cells are one component of a multi-species collective that has been co-evolving for hundreds of millions of years.
The gut microbiome receives most of the attention, but the holobiont’s ecosystems extend across every surface exposed to the environment. The skin hosts bacteria, fungi, and Demodex mites living in hair follicles. The oral cavity supports complex biofilms on teeth and tongue. The lungs — once thought sterile — have their own distinct microbial community. Every surface maintains a distinct ecosystem in dynamic equilibrium, regulated not by elimination but by the immune system’s continuous dialogue with its microbial partners.
The bacteriophage layer adds another dimension. Viruses predating on specific bacterial populations are part of the ecosystem’s regulation — not pathogens but population managers, keeping the microbial community in balance through predation pressure that mirrors the ecological role of predators in any other ecosystem. The FLORASSIST targeted phage supplement addresses this layer specifically, supporting the phage population that regulates harmful bacteria rather than eliminating bacteria wholesale with antibiotics.
The gut-associated lymphoid tissue constituting 70-80% of the immune system is not separate from the microbiome — it is in continuous calibration with it. The immune system learns through exposure. The hygiene hypothesis’s central finding: reduced microbial diversity produces immune systems inadequately calibrated, responding to harmless antigens as if they were threats. The ecosystem and the immune system are not two systems. They are one.
The Microbiotic Diet feeds an ecosystem whose boundaries were never as clear as the individual organism model assumed. The bacteria in the gut are symbiotes. The bacteriophages regulating them are part of the ecosystem. The viral sequences in the genome are part of the organism. The line between the human and the microbial, between the self and the symbiote, between the organism and its environment — these are gradients, not walls. The Microbiotic Diet is the dietary strategy that recognizes the gradient and feeds accordingly.
Feed the ecosystem. You are more of it than you think.
The mitochondria in every cell of the body were originally ancient bacteria — proteobacteria that entered into a stable symbiosis with an archaeal host approximately 2 billion years ago and never left. They retained their own circular DNA, their own bacterial ribosomes, their own binary fission replication. The host retained access to oxidative phosphorylation — the metabolic efficiency that powers all complex life. Neither partner subsequently existed independently. A 2 billion year old bacterium, invited to stay.
That ancient partnership requires maintenance. CoQ10 — declining with age and devastated by statin medications — supports the electron transport chain that the bacterial machinery runs. PQQ stimulates mitochondrial biogenesis, generating new mitochondria to replace damaged ones. Astaxanthin inserts into the mitochondrial membrane’s inner and outer lipid bilayers simultaneously, protecting the double membrane that the original proteobacterium carried into the symbiosis and has retained ever since. ALCAR shuttles fatty acids across the mitochondrial membrane for oxidation. The “mitochondrial support stack” is the care and feeding of the oldest symbiote in the body.
When antibiotics damage mitochondria as a side effect, it is because mitochondrial ribosomes are bacterial ribosomes. The antibiotic cannot distinguish the pathogen from the ancient partner. Two billion years of symbiosis, and the immune pharmacopeia still hasn’t fully learned the difference.
Gene-Environment Interaction: The Framing Most Medicine Gets Wrong
The standard medical framing of genetic risk is binary: you either have the gene or you don’t, and if you have it, your risk is elevated. The more sophisticated framing — the one that explains why identical twins with identical genomes develop different diseases at different rates — is gene-environment interaction. The gene loads the gun. The environment pulls the trigger.
BRCA mutation carriers illustrate the framing’s clinical importance. A BRCA mutation substantially elevates lifetime breast cancer risk. But BRCA carriers who modify their hormonal environment through diet, weight management, and specific lifestyle interventions have measurably lower cancer incidence than BRCA carriers who don’t — the same gun, different trigger conditions. Angelina Jolie’s prophylactic mastectomy made headlines. The environmental modification approach that reduces trigger probability in BRCA carriers received considerably less attention. One approach generates surgical revenue. The other generates nothing billable.
The MTHFR A1298C variant — affecting approximately one-third of the population — impairs the methylation of folate to its active form, 5-methyltetrahydrofolate (5-MTHF). The consequences are specific: impaired BH4 synthesis, which is required for serotonin production, producing a familial low-serotonin profile that loads the gun for depression, anxiety, and the artistic temperament that is depression’s functional cousin. One-third of depressed individuals have folate deficiency as a contributing factor. Depressed individuals with low folate don’t respond to SSRIs — the pharmaceutical is addressing a serotonin reuptake mechanism while the serotonin synthesis deficit from impaired BH4 remains unaddressed. The correct intervention is 5-MTHF specifically — the only form of folate that crosses the blood-brain barrier and bypasses the impaired enzyme entirely.
DNA testing now makes this analysis available to anyone. The 23andMe raw data run through a methylation analysis tool identifies MTHFR status within days. The cardiovascular risk from ApoE variants, the inflammation tendency from IL-6 variants, the caffeine metabolism from CYP1A2 variants that determines whether your morning coffee is cardioprotective or cardiotoxic — all identifiable, all actionable, all completely invisible to the standard medical workup that measures cholesterol and blood pressure and considers the genetic substrate unremarkable.
The familial risk profile revealed through DNA testing and family history is the most precise personalization of the protocol available. The specific risks on both sides of a family tree are not destiny. They are the loaded guns that the protocol keeps fingers off of. The gene that took my grandfather at fifty-nine and my cousin at fifty-eight might be in me too. The endothelial function architecture, the blood glucose management stack, the cardiovascular polyphenol protocol, the decades of daily exercise — these are what keep the trigger from being pulled.
They refuse to ask the questions that need to be asked because they are afraid of the answers.
The correct response to a family history of cardiac disease at fifty-eight is not to wait for the event and respond with a statin. The correct response is to understand the gene-environment interaction, identify the specific variants involved, and build the environmental architecture that changes what the gene encounters. How do we know the gene is “amenable to environmental modifications”? Because that gene would not be there if it was not adaptive in some past environment! Just maybe our distant ancestors did not live on twinkies, chips, and soda pop.
This is medicine as the Anticipatory Principle. This is looking both ways before crossing the street.
The Modern Food Environment: The Crap Changed
Americans have been lazy and eating poorly for at least a century. Drive-in restaurants, television, white bread, TV dinners, suburban sedentary living — none of this is new. The behavioral conditions that the conventional obesity narrative blames were present and normalized for decades before this new obesity epidemic accelerated. Obesity rates stayed relatively flat through the 1950s, 60s, and 70s and into the 80s. Then something changed in the 1990s and 2000s and the curve bent sharply upward.
The lazy crap-eating didn’t change dramatically. The crap changed.
The timing is not ambiguous. “Roundup Ready” GMO crops introduced in 1996 beginning the exponential growth in dietary glyphosate exposure — a patented antibiotic that disrupts gut microbiome composition in ways now being connected to metabolic dysfunction, obesity, and insulin resistance. “GMO” these days covers much more than the simple plasmid insertions that started it. A whole chapter could be written about the coverup of the dangers associated with the new GMO technologies. See the article in the references. High fructose corn syrup replacing sugar across the processed food supply as it became cost-competitive in the 1980s and 90s. The low-fat dietary guidelines of the 1970s producing processed food reformulated with sugar and refined carbohydrates to maintain palatability — the low-fat era’s paradox, in which Americans followed the dietary advice and got fatter. The use of PFAS, BPA, and phthalates , all endocrine disruptors, exploded in the 1990’s.. Post-1990 ultra-processed food containing emulsifiers — carboxymethylcellulose, polysorbate 80, xanthan gum — specifically shown to disrupt the gut microbiome’s metabolic function and drive the low-grade inflammation that produces insulin resistance independently of caloric content. The omega-6 to omega-3 ratio in the American diet reaching 15-20:1 as industrial seed oils replaced animal fats following the dietary guidelines.
All of these changed simultaneously with the obesity curve’s inflection point.
My informal but reliable population monitoring tool: the Swimming Pool Index. What fraction of people at the swimming pool — particularly younger people — are visibly obese? The pool self-selects for people willing to appear in minimal clothing, historically a filter that produced a sample biased toward those comfortable with their physique. When even this filtered sample has shifted dramatically toward obesity in recent years, the underlying population shift is considerably worse than the index suggests.
This has changed dramatically in just the past 5 years. The pool that once attracted a representative cross-section of bodies now sits largely abandoned — deck chairs, blue water, the hum of the filtration system — waiting for occupants who are now too embarrassed to be seen. The pool is now a Liminal Space. The infrastructure of a social world sits empty, waiting for a population that no longer shows up.
The obesity epidemic has two simultaneous components that the conventional behavioral narrative conflates. The first is what people eat — which has genuinely changed in the ways documented above. The second is that the food supply was specifically engineered to defeat the stop signal.
The satiety signaling architecture — GLP-1, leptin, ghrelin, gastric stretch receptors, peptide YY — is a sophisticated multi-redundant system designed to produce the stop signal. It works. It worked for hundreds of thousands of years before the food industry employed scientists specifically to defeat it. The bliss point — the precise fat-sugar-salt-texture combination that overrides satiety — was not discovered accidentally. It was engineered deliberately. The population isn’t weak. The signal is broken. These are different problems with different solutions.
The pharmaceutical response to the broken signal is GLP-1 agonist injections at $1,000 per month. I noticed decades ago that oregon grape root taken after vigorous exercise seemed to completely remove my appetite, and science now shows that it stimulates endogenous GLP-1 production, for $8 a bottle. The food response is caloric restriction and the Anticipatory Principle applied to meal composition. The upstream response is not eating the food that broke the signal in the first place.
The same industry ecosystem engineered the disruption and profits from the pharmaceutical correction. The tobacco industry optimized nicotine delivery and then sold smoking cessation products. The food industry engineered the bliss point and then their pharmaceutical partners sell semaglutide. The addict is blamed in both cases. The engineering is not discussed.
Getting the Right Fats: Thirty Years of Development
The modern American doesn’t just eat too much fat. They eat the wrong fats at the wrong ratio — a ratio systematically engineered to be wrong by the seed oil displacement that followed the low-fat dietary guidelines. The omega-6 to omega-3 ratio of 4:1 is not an arbitrary recommendation. It is the ratio that human cellular machinery was built around over hundreds of thousands of years of eating fish, wild animals, olives, nuts, seeds, and avocados. Every cell membrane in the body reflects the dietary fat composition of the individual who built it. Change the fat composition and you rebuild every cell membrane in every tissue with different material. The seed oil replacement shifted that ratio to 15-20:1. The inflammatory signaling machinery calibrated to 4:1 began running at five times the inflammatory input the genome expects.
Trans-fats — produced by partial hydrogenation of vegetable oils to extend shelf life and achieve solid texture at room temperature — deserve specific mention as the most dangerous dietary fat humans have ever consumed at scale and the clearest example of the “experts” getting it wrong. For decades the same expert opinion that condemned saturated fat recommended margarine as the heart-healthy alternative. Margarine was primarily trans-fat. The substitute produced by industrial food chemistry to replace the naturally occurring animal fat was categorically more harmful — raising LDL, lowering HDL, promoting inflammation, and crossing the blood-brain barrier where saturated fat largely does not. The FDA finally banned partially hydrogenated oils in 2018. The recommendation that caused millions to switch from butter to margarine was wrong in both directions simultaneously: it condemned a natural fat that the human body has metabolized for millions of years and replaced it with an industrial product the human body had never encountered.
I had to personally discover what the experts missed the hard way: skin that changed texture and color, acne breakouts, and visible inflammation after a single trans-fat meal — the body’s most immediate communication that something foreign and incompatible had been introduced. What I had was a visible immune system response. The Nose Knows. The skin knows. The experts, apparently, did not.
Trans-fats are now largely eliminated from the American food supply following the FDA ban. The damage they caused across the decades of their recommended use is not.
What I eat strongly depends on its good fat content:
The cooking oil foundation. Olive oil as the primary cooking and dressing oil — the oleocanthal providing anti-inflammatory activity, the oleuropein protecting the endothelium, the oleic acid making it a neutral participant in the omega-6:omega-3 ratio rather than an amplifier of it. Coconut oil for Asian cooking specifically — medium-chain triglycerides routing directly to the liver for rapid energy conversion rather than requiring the carnitine transport that long-chain fats require, with ketone production as a metabolic byproduct that the brain uses alongside glucose. No industrial seed oils. The principle is simple: olive oil where the Mediterranean diet used olive oil, coconut oil where Southeast Asian cooking traditionally used coconut oil, and nothing that required industrial processing to produce. And yes, sometimes those recipes require butter.
[Not all butter is equivalent. Grass-fed butter from cows eating their evolutionary diet rather than grain carries a better omega-3 to omega-6 ratio, substantially higher CLA content, and more vitamin K2 than conventional dairy — the fat’s nutritional profile reflecting the animal’s diet as directly as human cellular composition reflects ours. The taste difference between grass-fed and conventional butter is not subtle. Grass-fed butter is richer, more complex, slightly golden from the beta-carotene in the grass, and melts cleanly. Conventional butter from grain-fed dairy is chalky, coats the tongue, and tastes very little by comparison.]
The whole food fat sources. Avocados as a daily staple — the most nutrient-dense whole-food monounsaturated fat available, with lutein for the macular protocol, potassium exceeding bananas, and a documented property that distinguishes whole food avocado from supplemental fat: the fat matrix dramatically improves absorption of fat-soluble phytonutrients from foods eaten alongside it. The carotenoids in a salad become three to five times more bioavailable when eaten with avocado. The avocado is not just a fat source. It is a bioavailability amplifier for every fat-soluble compound consumed in the same meal.
The ground seed blend. Equal parts sesame seeds, flaxseeds, and chia seeds — ground fresh in the coffee grinder and stored refrigerated to prevent oxidation of the highly unsaturated components. Each contributes something the others don’t. This makes an excellent topping to yogurt for breakfast.
Sesame seeds contribute sesamin and sesamolin — lignans that inhibit delta-5 desaturase, the enzyme responsible for converting DGLA (the beneficial anti-inflammatory omega-6) to arachidonic acid (the pro-inflammatory omega-6 driving the 20:1 ratio’s consequences). Most dietary approaches to improving the ratio focus on adding omega-3. The sesame lignan approach addresses the omega-6 conversion pathway directly — blocking the step that makes abundant dietary omega-6 most damaging. Sesaminol simultaneously protects the polyunsaturated fats in the blend from oxidative degradation.
Flaxseeds contribute ALA omega-3 at approximately 22g per 100g — the highest plant concentration available — alongside secoisolariciresinol diglucoside, a lignan precursor that gut bacteria convert to enterolactone and enterodiol with documented cardiovascular and hormonal benefits. Unground flaxseeds pass through the GI tract largely intact; the seed coat is designed by the plant to resist digestion. Grinding is not optional — it is the difference between delivering the nutrition and decorating the stool.
Chia seeds contribute ALA omega-3 alongside a gel-forming soluble fiber property: when chia contacts gastric fluid it forms a physical gel that slows gastric emptying and carbohydrate absorption. The blood glucose management connection runs simultaneously with the fat delivery. The same yogurt bowl that delivers the fat blend is having its glycemic response modulated by the chia fiber mechanically — the CinSulin protocol’s enzyme inhibition doing pharmaceutically what the chia does structurally.
The supplement layer. Four softgels of IFOS-certified Super Omega-3 EPA/DHA daily delivering 1.4g EPA and 1g DHA from certified wild fish oil, with Polyphen-Oil olive polyphenols and sesame lignans embedded in the formula — the Mediterranean diet principle in a capsule. One krill oil capsule delivering phospholipid-form EPA and DHA for direct neural membrane incorporation, bypassing the triglyceride conversion step that standard fish oil requires. The two forms complement rather than duplicate: fish oil’s triglyceride EPA and DHA for systemic cardiovascular and anti-inflammatory effects, krill oil’s phospholipid EPA and DHA for direct cellular and neural membrane incorporation.
The fish diet. Sardines almost weekly — base of the food chain, maximum omega-3 density, minimum mercury accumulation, the whole-food taurine matrix. Occasional sushi. A weekly dinner of fish or shrimp. The fish protocol is not a supplement strategy. It is the dietary foundation that the supplements extend and reinforce.
The entire fat architecture was not designed from a chart. It was assembled from thirty years of reading, experimentation, and observation. Each component was added when the evidence justified it. What resulted is the Show Me standard applied to dietary fat biochemistry.
Carbohydrates: The Problem Is Never the Carbohydrate — It’s the Delivery Rate
The problem is not carbohydrates. It is the delivery rate.
The human brain is approximately two percent of body weight and consumes approximately twenty percent of the body’s glucose. It is the most metabolically demanding organ in the body. Its primary fuel is glucose. The brain runs on carbohydrates. The question is not whether to eat carbohydrates. It is which carbohydrates, in what form, delivering glucose at what rate.
The ancestral human diet was never low-carbohydrate. It was fiber-dense and full of cellular structure. It was Nature’s magic time-release formulation. Tubers, wild fruits, legumes, seeds — all with their fiber matrix intact, all delivering glucose slowly, all feeding the gut microbiome simultaneously with the fermentable fiber that gut bacteria require for the butyrate production that maintains the intestinal barrier. Food processing removed the fiber and structure from every carbohydrate it touched, in effect, making food pre-digested. What remained was a quick glucose delivery mechanism without the time-release packaging.
The absence of sweet craving after decades of clean eating is not willpower. It is gut microbiome adaptation. The bacteria that produce sugar craving — Firmicutes strains that metabolize simple sugars and signal demanding more substrate — decline when their food source is removed. The bacteria that produce satiety signals — Bifidobacterium, Lactobacillus, Akkermansia — expand when fiber-rich whole carbohydrates become the primary substrate. The gut-brain axis shifts accordingly. After sufficient time without added sugars, the craving signal stops being generated because the organism generating it has been outcompeted. Not suppressed. Absent.
The specific avoidances are mechanistically grounded:
Fruit juice removes the time-release mechanism while leaving concentrated sugar delivery. Orange juice has essentially the same glycemic response as soda pop. The vitamin C is present. The fiber matrix that made the orange a time-release carbohydrate is not. The medical establishment that warns against soda while recommending fruit juice has not read the glucose monitor data.
Soda delivers the glycemic impact combined with phosphoric acid, HFCS, and — in diet versions — artificial sweeteners with documented gut microbiome disruption. Nothing is more concentrated as a problem per unit volume consumed.
Refined starches — bread, pasta, chips, corn-based products — have had the fiber matrix removed. The glucose delivery rate of white bread exceeds that of table sugar on the glycemic index. The “complex carbohydrate” label on refined grain products is biochemically misleading: the complexity of starch chains is irrelevant when the amylase enzymes that break them down operate faster than the absent fiber could have slowed them.
Corn specifically carries an additional dimension beyond glycemic index: virtually all commercial corn that is not organic now has multiple “stacked traits” of inserted pesticide resistance genes. The pesticides used have been documented to show up in the harvested grain. The carbohydrate argument for avoiding it is compelling. The pesticide argument makes it mandatory.
Natural carbohydrates with their fiber matrix intact are not merely acceptable. They are necessary. The blueberries and strawberries on the yogurt bowl. The banana on the keto granola. The lentils. The apple eaten whole. Each delivers glucose into a fiber matrix that slows absorption, feeds beneficial gut bacteria through fermentation, and provides the sustained brain fuel that the organ running the entire protocol depends on.
The most important carbohydrate recommendation in this section is not a food list. It is a measurement recommendation. A continuous glucose monitor — now available over the counter without prescription — worn for two weeks of normal eating produces more instructive dietary data than any guideline ever published. Watch what happens after pasta or corn chips. Watch what doesn’t happen after lentils or raw carrots. The data specific to your own metabolic response is more useful than the population average in any table.
A note on grain selection that belongs alongside the general carbohydrate principles: the grain matters as much as the quantity. Modern high-yield wheat — Triticum aestivum, the hexaploid variety that Norman Borlaug’s Green Revolution optimized for maximum yield — has a dramatically different protein composition from the grains humans ate for ten thousand years before it was bred in the 1960s. The gliadin fraction specifically increased, producing higher gliadorphin opioid peptide potential and a different immune response profile from ancestral wheat. Einkorn, the original domesticated wheat with the lowest gliadin content and a different structural configuration, kamut with its ancient protein profile and superior mineral density, teff with its Ethiopian highland mineral matrix and complete absence of conventional gluten, sorghum with its resistant starch gut microbiome support and documented glucose-lowering polyphenols — these are the actual ancestral grains. They are what the carbohydrate delivery rate argument assumes when it says “natural carbohydrates are healthy brainfood.” The one weekly baguette of modern wheat is the exception. The heirloom grain protocol is the rule.
I was almost shocked to feel an endorphin rush from eating a baguette after several weeks without. Do we really want to be addicted to wheat? Gliadorphins. Opioid peptides from partial gliadin digestion. The pharmacological response that explains bread’s remarkable resistance to dietary elimination. The grain protocol uses the grains that don’t produce that response. One crusty baguette per week, with eggs or soup.
One underappreciated dimension of the carbohydrate delivery rate argument is grain selection. Modern high-yield wheat — the hexaploid Triticum aestivum optimized by Norman Borlaug’s Green Revolution breeding programs in the 1960s — has a fundamentally different protein composition from the grains humans adapted to over ten thousand years of agriculture. The gliadin fraction increased dramatically, producing higher gliadorphin opioid peptide potential that partly explains bread’s remarkable resistance to dietary elimination: it is mildly addictive through a documented opioid mechanism. The personal demonstration: after several wheat-free weeks, a single baguette produced an endorphin rush that had no precedent in the preceding years of regular consumption. Upregulated opioid receptors meeting reintroduced gliadorphins.
The strategic response is heirloom grain selection. Einkorn — the original domesticated wheat — contains the lowest gliadin content of any wheat variety with a structurally different configuration that lacks the most problematic D-genome fraction. Kamut carries an ancient protein profile and superior mineral density. Teff, the Ethiopian staple, belongs to a completely different botanical family from wheat with no conventional gluten and a mineral matrix reflecting volcanic highland soils. Sorghum, equally unrelated to wheat, provides resistant starch that feeds gut microbiome fermentation and polyphenols with documented glucose-lowering effects. These are the grains humans actually adapted to. Using them in place of modern commodity wheat flour is not a sacrifice of culinary function — blueberry pancakes made with yogurt instead of milk on heirloom flour are extraordinary — it is a return to the food the carbohydrate metabolism was designed to handle.
The one weekly baguette of modern wheat is the exception in a grain protocol otherwise running on ancestral varieties. The endorphin rush it occasionally produces is the reminder of what the exception costs.
The Protein Problem
This is contested material — which is itself the most important signal. When the food industry funds the research and designs the dietary guidelines, the argument is always contested. The meat, dairy, and cheese industries have spent seventy years defining the “right amount” of protein as the amount their products deliver, and the official recommendations arrived at that number through the normal process of regulatory capture.
The primary literature tells a different story.
The Levine 2014 Cell Metabolism study — 6,381 Americans from NHANES III followed for 18 years — found that high animal protein intake in middle-aged adults (50-65) was associated with four times the cancer mortality risk of low protein intake. A risk comparable in magnitude to smoking. All-cause mortality was 74% higher. The senior author stated: “We studied simple organisms, mice, and humans and provide convincing evidence that a high-protein diet — particularly if the proteins are derived from animals — is nearly as bad as smoking for your health.” These associations nearly disappeared when the protein came from plants rather than animals.
The 2020 BMJ meta-analysis of 32 cohort studies, 715,128 participants, 113,039 documented deaths: higher plant protein intake was significantly associated with lower all-cause mortality and lower cardiovascular mortality. Animal protein showed null to harmful associations.
The mechanism is not mysterious. Animal protein — particularly its leucine, methionine, and branched-chain amino acid load — powerfully activates mTOR, the cellular growth switch that every longevity intervention in this book is simultaneously trying to suppress. High animal protein intake is doing to the mTOR pathway what caloric restriction, intermittent fasting, HIIT exercise, and the entire senolytic supplement stack are trying to undo. The two approaches are working against each other.
The gut microbiome adds a second independent mechanism. Gut bacteria that dominate in meat-eating populations convert the choline and L-carnitine in animal protein to trimethylamine, which the liver converts to TMAO — a proatherogenic metabolite promoting atherosclerosis, endothelial dysfunction, platelet activation, and kidney damage. The gut microbiome of a lifetime pesco-vegetarian produces dramatically less TMAO from equivalent dietary choline because the bacteria that generate it have been outcompeted by decades of plant fiber feeding Bifidobacterium and Lactobacillus. The Microbiotic Diet is simultaneously a TMAO reduction protocol.
The observation that higher protein intake appears protective in adults over 65 has been used to argue that protein restriction doesn’t apply to the elderly. The confounding variables make this interpretation untenable. Elderly Americans who reduce protein intake are disproportionately doing so because they are already in declining health — reverse causation that statistical adjustment cannot fully correct. More importantly, the “low protein” elderly cohort in American observational studies is not practicing deliberate, nutrient-adequate protein moderation. They are eating less of everything — fewer calories, fewer micronutrients, fewer omega-3s, less B12, less zinc, less CoQ10, less of every compound the Annual Increment chapter documents as critical to mortality outcomes. What is measured as a “protein effect” is the compounded deficiency of simply eating less of an already nutritionally inadequate diet.
The correct comparison — protein-moderated elderly adults with full micronutrient adequacy against high-protein elderly adults with equivalent total nutrient intake — has never been conducted. It has not been funded because confirming that the “elderly need more protein” signal is a statistical artifact of compounded deficiency would not serve the industries whose products deliver that protein.
My father was seventy when I took him back to Stephenson’s Apple Farm — the Kansas City restaurant he used to take us to when we were children. He loved the experience, the family, the memories. He ordered his old favorite of fried chicken with all the extras. He took one bite and was done.
Not from discipline or restraint. His body, at seventy, could no longer handle what his body had loved at fifty. The diabetes, the cardiovascular damage, the frailty accumulating for decades — all arriving at once at a table he loved. He died four years later, which was the inevitable consequence of deciding that life was no longer worth living.
The establishment would have declared about my father, “insufficient protein intake”.
The diagnosis that costs nothing to make, implicates nothing that was done before, and requires no confrontation with the decades of dietary choices and institutional recommendations that produced the man at that table. The food industry’s most efficient achievement: framing the endpoint of its own product as a deficiency to be corrected with more of the same product.
Larry needed protein the way the Titanic needed a better bilge pump. The ship was not sinking because the pump was inadequate.
The right amount of protein is the amount required for muscle maintenance and cellular function without the chronic mTOR activation, IGF-1 elevation, TMAO production, and uric acid accumulation that excess animal protein produces over decades. For most middle-aged adults eating the standard American diet, that means considerably less animal protein than currently consumed — and a fundamental shift toward plant protein, fish, and fermented dairy rather than red meat and processed cheese.
The carnivore diet influencers who claim to be eating ancestrally are not. The anthropological evidence is unambiguous: hunter-gatherers worldwide get roughly half their calories from plant foods. The Hadza of Tanzania — name-checked by carnivore advocates as proof of meat-based ancestral eating — get almost 70% of their calories from plants. The Kung and Hadza fail to get meat more than half the time they hunt. “Everybody thinks you wander out into the savanna and there are antelopes everywhere, just waiting for you to bonk them on the head,” says paleoanthropologist Alison Brooks of George Washington University.
Our ancestors were not hiding in tree stands waiting for game to wander past. The anthropological evidence describes hunter-gatherers who spent far more time gathering than hunting — tubers, fruits, seeds, legumes, insects, occasional game. Meat was a periodic feast, not a daily entitlement. The metabolic machinery evolved for intermittent protein abundance, not chronic high-protein maintenance. The result of running ancestral machinery on non-ancestral fuel is the cardiovascular disease, gout, kidney strain, and mTOR chronic activation that the American diet produces at population scale.
The chronic American diseases that parallel the rise of high-protein dietary culture are not coincidental. Gout — the direct metabolic consequence of purine metabolism from excess animal protein, producing uric acid crystals in joints — is the most obvious. Cardiovascular disease is the most deadly. The biochemical evidence compounds the anthropological case. The human immune system produces an inflammatory response to Neu5Gc, a sugar found in red meat, that is low-level in the young but accumulates over decades — potentially explaining the cancer and cardiovascular associations that emerge with age and long-term meat consumption. A 2024 University of Missouri study published in Nature Metabolism identified the specific mechanism: leucine, the amino acid concentrated in animal protein, triggers macrophage signaling that at normal levels clears arterial plaque but at chronically elevated levels produces the plaque accumulation it was designed to prevent. The threshold identified was 22% of daily calories from protein — the level the ancestral diet rarely if ever sustained. The typical American diet, with meat at every meal, routinely exceeds it.
Meat has its place when you are young if you want to quickly grow big and strong, but continuing with that dietary choice has consequences. This book is not titled, “How to Die Sooner”.
Blood Sugar: The Total Package
The blood glucose management protocol described below is not life extension. It is curve-squaring. About 3/4ths of Americans over 65 have one of more of metabolic syndrome, diabetes, and obesity, and 1/3rd of them will die prematurely from them. These are pretty typical conditions on my mom’s side, so I take extra effort to address this increased risk. More than likely you will need to also.
The six-compound glucose management architecture running simultaneously:
Cloves and Cinnamon in the herb tea, all day. Three independent mechanisms cloves: enhanced glucose uptake into muscle cells by up to 63%, liver gluconeogenesis inhibition, and alpha-glucosidase and amylase inhibition reducing carbohydrate absorption at the intestinal level. Two mechaniss for cinnamon: delaying glucose absorption from the intestines plus enhances the effect of insulin. No currently available pharmaceutical accomplishes all five simultaneously. The all-day tea provides sustained coverage across both fasting and feeding periods — pharmacokinetically superior to the once-daily capsule used in clinical trials.
Amla powder in the morning vitamin C glass. Controlled clinical trial showing significant decreases in both fasting AND two-hour post-prandial blood glucose in both normal and type 2 diabetic subjects at 21 days. The Ayurvedic tradition prescribed amla for millennia. The mechanism arrived in the peer-reviewed literature in 2011. The powder had been in the morning glass for over a decade before the first LEF article on its cardiovascular benefits appeared.
CinSulin with InSea2 and Crominex® taken 30 minutes before starchy meals. The Anticipatory Principle in precise form: CinSulin activating cellular glucose detection systems before the baguette arrives, InSea2 seaweed phlorotannins inhibiting glucosidase and amylase before the substrate reaches the intestinal enzymes, Crominex stabilized chromium enhancing insulin receptor sensitivity through a mechanism independent of all other glucose management compounds.
Berberine BerbEVIS twice daily after meals. AMPK activation comparable to metformin in head-to-head trials. Ceramide reduction addressing the lipotoxic intermediates through which metabolic syndrome progresses to NAFLD. Simultaneously the cheapest known GLP-1 stimulant available — Oregon grape root, the primary berberine plant, producing post-workout appetite suppression observed decades before the GLP-1 mechanism was characterized. The pharmaceutical industry sells the GLP-1 signal back at $1,000 per month. The herb achieves part of the same effect for $8.
The caloric restriction foundation. The 1,200 calorie daily protocol that began the yogurt years. The 16:8 fasting window that maintains metabolic flexibility. The HIIT protocol generating AMPK activation and improving insulin sensitivity through the most powerful physiological mechanism available.
The dietary architecture. No added sugars. No fruit juice. No soda. No refined starches as staples. Natural carbohydrates in their fiber-intact whole food form — the blueberries, the strawberries, the banana on the keto granola, the lentils, the apple eaten whole. The chia’s gel-forming fiber physically slowing gastric emptying for everything consumed alongside it.
Six compounds, five lifestyle interventions, one dietary framework — all addressing the same metabolic target from independent directions simultaneously. The gun is loaded. Six fingers are on the trigger guard.
For circumstances involving unavoidable carbohydrate loading — the holiday meal, the special occasion, the baguette that exceeds the weekly protocol — Tri Sugar Shield addresses blood sugar from three independent entry points taken immediately before eating. Sorghum bran extract modulates liver glucose production and inhibits alpha-amylase, slowing starch breakdown during digestion. Mulberry leaf extract inhibits alpha-glucosidase in the gut while supporting GLUT4 transport to move glucose into muscle cells rather than leaving it in circulation. Phloridzin — an apple polyphenol — targets the SGLT1 and SGLT2 kidney transport proteins to reduce glucose reabsorption and encourage elimination. The SGLT2 inhibitor drug class that pharmaceutical companies developed and patent-protected is derived from phloridzin. The apple polyphenol arrived first.
This is an intervention for special circumstances, not daily use. The dietary protocol is the first line. The anti-glycation stack is the second. Tri Sugar Shield is the acute response to the unavoidable exception.
Keeping blood sugar in a healthy range is the first line of defense. It is not the only line. Even at levels considered normal, glucose continuously damages proteins throughout the body through the process of glycation — glucose binding to proteins to form Advanced Glycation End Products (AGEs) that are aptly named. The damage accumulates in blood vessels, nerves, kidneys, the eye’s lens and retina, heart muscle, and brain. Every aging person is accumulating it, diabetic or not.
The anti-glycation stack addresses the damage that slips through despite the dietary protocol:
Carnosine — a dipeptide of beta-alanine and L-histidine found naturally in muscle and brain tissue — reacts directly with glucose and its toxic byproducts before they can bind proteins, effectively sacrificing itself to intercept the glycation reaction. A human randomized controlled trial at 2,000mg daily showed insulin resistance increase was 3.8-fold lower in the carnosine group than placebo, and insulin secretion increase was 3% versus 36%. It protects the kidney’s filtering function, prevents cataract progression in diabetic models, shields the retina from vascular damage, stabilizes atherosclerotic plaque, and crosses the blood-brain barrier to protect against beta-amyloid toxicity. The Super Carnosine formula uses an enhanced absorption form.
Benfotiamine — the fat-soluble form of thiamine (vitamin B1) — activates the transketolase enzyme that diverts glucose metabolites away from the four damage pathways that produce diabetic complications: AGE formation, protein kinase C activation, hexosamine pathway, and polyol accumulation. Standard water-soluble thiamine cannot reach the tissue levels that benfotiamine achieves.
Alpha-Lipoic Acid (ALA) is the only antioxidant that is both water and fat-soluble simultaneously — protecting membranes and cytoplasm while regenerating vitamins C and E and glutathione. A landmark study by Bruce Ames in the Proceedings of the National Academy of Sciences showed ALA increased glucose uptake by up to 300% in insulin-resistant muscle cells. It has been used in Germany for over 30 years for diabetic neuropathy. It protects the kidney from glucose-induced damage and synergizes powerfully with ALCAR.
Acetyl-L-Carnitine (ALCAR) — already in the protocol for mitochondrial fatty acid transport — completes the quartet. The Ames study showed ALA and ALCAR together significantly outperformed either alone in restoring metabolic function and reducing oxidative damage. ALCAR improves glucose storage at the cellular level and supports the neurotransmitter synthesis that glucose-induced brain damage impairs.
The total package includes both prevention and protection.
Nobody’s Perfect
Let me be direct about something that every other section in this book carefully avoids: the protocol described here is not a complete solution. It is the best available response to a problem that is changing faster than the science can characterize it.
Consider the personal data. A workout that moves six tons of weight per session. A daily caloric intake of approximately 1,200 calories. No identified dietary deficiencies — a supplement stack specifically designed to close every gap the modern food supply and aging process produce. Forty years of consistent implementation. By every conventional model of weight management, the mathematics should not permit weight gain. And yet.
When every variable inside the protocol is controlled and has been for decades, the variable causing an anomalous observation must be external. This is not speculation. It is the only logical conclusion available from the data. The physicist who corrects the wrong answer on the exam applies the same reasoning here: when the observation doesn’t fit the model, you don’t adjust the observation. You look for what the model is missing.
What the model is missing is not inside the protocol. Something external is operating — something powerful enough to partially override a protocol that includes six tons of weekly weight moved, 1,200 calorie daily intake, no identifiable deficiencies, and the complete blood glucose and weight management supplement architecture. Whatever it is, it is getting worse at an accelerating rate that is observable at the swimming pool on an annual timescale. The pool that was attracting a few people last year is now abandoned. That rate of change — a single year producing a visible population-level shift — cannot be explained by behavioral drift or dietary change. Bodies and behaviors don’t change that fast. Exposures can.
The named candidates are collected under the term obesogens — compounds that specifically reprogram fat cell biology independently of caloric intake, triggering differentiation of pre-adipocytes into mature fat cells, increasing fat cell number and size, and altering the hormonal signaling that governs energy storage. The identified members of this class include BPA and its chemical substitutes (introduced as “BPA-free” solutions that in many cases proved worse than what they replaced), phthalates from plastic food packaging, PFAS from food-contact materials and non-stick cookware, atrazine from agricultural runoff, and organotins from the marine food chain. The glyphosate-gut microbiome pathway — Roundup Ready crops entering the food supply in 1997, glyphosate acting as a broad-spectrum antibiotic disrupting gut flora and altering the bile acid metabolism and fat storage signaling that healthy microbiome composition regulates — belongs in this category even though it arrives as a food contaminant rather than a packaging chemical.
But the term “obesogens” may be too narrow for what is currently happening. These compounds could be arriving in food, in water, in packaging, in cookware, in the air, in your clothes, etc; we just don’t know yet! The microplastics now measurable in human blood, breast milk, and placental tissue carry chemical passengers that haven’t been individually characterized. Nanoplastics — small enough to cross the blood-brain barrier — are appearing in human brain tissue in autopsy samples at concentrations that appear to roughly double every five years. They are airborne as well as food and water-borne. You are breathing them. The plastic additive universe contains thousands of compounds, most with no toxicological characterization at all. Only recently did we find out much sportswear leaches endocrine disruptors into the skin.
What changed specifically in the past five years — producing the acceleration that even a rigorous protocol doesn’t fully overcome — is not yet understood. This is the honest statement. Not “the evidence is mixed” or “more research is needed” — the standard institutional deflection. The specific honest statement is: something is happening to human fat cell biology and metabolic regulation at a population scale and an individual scale that the current science cannot yet fully name, and it is getting worse faster than the science can characterize it.
The weight loss stack documented in the preceding chapter is the response: expanded protocol, increased intervention, continued monitoring. The Anticipatory Principle applied to an incompletely characterized threat. We observe the effect clearly. We act on it with the best available tools. We cannot yet fully name the cause.
This is what scientific integrity looks like from the inside. Not the confident expert with the complete solution. The rigorous practitioner reporting an anomalous observation that the existing models don’t explain, naming the open question honestly, and continuing to adjust the protocol in response to new data.
Nobody is perfect. The environment is becoming less perfect faster than any individual protocol can fully compensate. The correct response is not despair and it is not denial. It is continued observation, continued adjustment, and the intellectual honesty to say plainly: we don’t have all the answers. The science isn’t finished. The protocol isn’t finished. And anyone telling you they have it entirely figured out hasn’t looked at the pool recently.
Just one example of a hidden threat which has only recently been in the news: the food supply contains an unknown number of substances whose safety has never been assessed by any independent authority. Under the GRAS — Generally Recognized as Safe — regulatory framework, companies may self-declare new food additives safe and bring them to market without FDA review or approval. The category was created in 1958 for ingredients like salt and yeast with centuries of documented human use. By 1997 it had been stretched to cover self-certification of novel industrial compounds.
Since 2000, approximately 766 new “GRAS” chemicals have been added to the food supply. Of those, only 10 involved companies petitioning the FDA for approval. The remaining 99 percent were self-affirmed by the companies adding them — no independent safety review, no requirement to notify the FDA, no public record. An estimated 1,000 to 1,200 ingredients currently carry self-affirmed GRAS status. Nobody knows the actual number because the pathway is secret by design: companies that self-affirm are not required to disclose they’ve done so. I put quotes around GRAS because the acronym should properly be formed from Company Recognized As Permitted.
Consumers eating foods containing these ingredients are, in a technical sense, participants in an uncontrolled safety trial.
In March 2025, HHS Secretary Kennedy directed the FDA to explore eliminating the self-affirmation pathway entirely. The FDA proposed a new oversight rule on August 10, 2026, now in public comment. Legal analysts consider full elimination unlikely near-term — the GRAS exception is embedded in the Federal Food, Drug, and Cosmetic Act itself and would require Congressional action to remove. Increased transparency requirements are the realistic near-term outcome.
No protocol is going to protect from the unknown.
That bus is getting harder to identify. It may be in the packaging your food came in, the water you drank, the air you breathed, or a compound the regulatory agencies haven’t characterized yet and may not get around to for another decade.
Look both ways. Then look in directions the conventional framework hasn’t thought to check. Then maybe don’t examine your lunch packaging too closely — some knowledge arrives faster than the solutions.
The Psychology: The Largest Obstacle
The physiological information in this chapter is available. Most of it has been available for decades. The research on dietary fat composition was substantially complete by the 1990s. The protein-mTOR-cancer connection was documented in the primary literature by 2014. The endothelial function mechanisms were characterized in the 2000s and 2010s. The gut-brain axis data is the most recent — but even there, the empirical tradition was ahead of the mechanism by centuries.
The obstacle is not informational. It is psychological.
The brain running on sugar, inflamed by the twenty-to-one seed oil ratio, impaired in its serotonin synthesis by MTHFR methylation deficits, operating on the gut-brain axis signals from a dysbiotic microbiome shaped by decades of ultra-processed food — that brain does not make optimal dietary decisions. It is not firing on all cylinders. The food choices that perpetuate the inflammatory state are also the choices that feel most rewarding in the moment to a brain running on that inflammatory state. The addiction is self-reinforcing because the addictive substance is impairing the decision-making apparatus that would recognize the problem.
You are what you eat is the most empirically supported claim in nutritional science. It is also the most psychologically resisted. Not because people don’t intellectually accept it — most people can acknowledge the principle in the abstract. The resistance is at the level of food choice, where the abstract principle meets the specific fried chicken, the specific soda, the specific bag of chips. The abstract principle loses to the immediate reward every time the decision-making apparatus is compromised by what the previous food choices have done to it.
This is not moral failure. It is the metabolic consequence of the modern food supply operating on the human reward system that evolved in a food environment of scarcity. The bliss point defeats the rational mind not because the rational mind is weak but because the food was engineered specifically to defeat it.
The intervention is not motivation or willpower. The intervention is changing the food environment, eliminating the substances that impair the decision-making apparatus, and giving the brain the substrate it needs to run the protocol that protects it. The amla in the morning glass improves endothelial function to the brain. The omega-3 rebuilds the neural membrane composition from which cognition arises. The berberine and AMPK activation improve the metabolic state from which food decisions are made. The 5-MTHF bypasses the MTHFR deficit that impairs serotonin synthesis and with it the capacity for sustained motivation.
The person asking “why can’t I stick to a diet” is often not asking a psychological question. They are asking a metabolic question with a psychological presentation.
Change the substrate. The decisions change. The tools described in this book make it considerably easier than it appears from inside the food environment that is killing you.
A Final Note
The protocol described in this book was not assembled from a single source or a single decade. It emerged from forty years of reading primary literature, watching what the evidence said, implementing what it justified, and observing what happened. The Show Me standard applied to one body, one protocol, one life.
The longevity literature almost universally reports median lifespan extension, which is the age at which half a cohort has died. This is what the statistics can detect with manageable sample sizes. Maximum lifespan, the age at which the longest-lived individuals die, is a different and far harder question. It is dominated by rare stochastic events, requires sample sizes of thousands to detect in animals and millions in humans, and has never been experimentally tested in a population running a comprehensive multi-pathway protocol from early adulthood. The experiment has not been done. The data does not exist.
Some of the C. elegans findings discussed in this book come closer to the maximum lifespan question than most. When a compound extends not just median but maximum lifespan in a short-lived organism — when even the longest-lived worms in the treatment group outlive the longest-lived controls — it suggests something more fundamental is being addressed than merely reducing the most common causes of premature death. The tyrosol data, the PQQ data, the caloric restriction data in C. elegans all showed this pattern. Whether the mechanisms translate to human maximum lifespan extension is genuinely unknown.
What is known: the protocol addresses all twelve official hallmarks of aging simultaneously. It reduces the most common causes of premature death through documented mechanisms. It addresses the environmental deficiencies that modern life has introduced. It supports the repair systems whose decline produces the acceleration of aging past sixty that feels exponentially harder every year because it actually is. Forty years in develop so far with a positive outcome, and it will undoubtedly continue to improve.
The woman at the gym who needed to confirm she had really seen the fit person at the pool — because a fit person in a swimsuit is now sufficiently rare to warrant cross-venue identification — is the Swimming Pool Index made personal. The protocol is producing the anomaly. The anomaly is noticeable because the baseline has changed so dramatically.
Whether this protocol extends maximum human lifespan remains unknown. Whether it substantially extends the healthy, functional, engaged years before that maximum is reached — the years that are worth having — the evidence strongly suggests yes. The distinction between dying at 80 after a decade of decline and dying at 90 after a decade of full engagement is not primarily a question of maximum lifespan. It is a question of what the years look like.
The baseline can change back. Not at the population level through dietary guidelines — the food industry writes those. At the individual level, one decision at a time, starting with the decision to look both ways before crossing the street.
And yes, sometimes those recipes require butter.
Leave a Reply